Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Laminin Rabbit anti-Human, Mouse, Rat, DyLight® 488, Polyclonal, Invitrogen™

Rabbit Polyclonal Antibody

Manufacturer:  Invitrogen PA522901

Catalog No. PIPA522901


Add to cart

Description

Description

This antibody is pan-specific and reacts well with all Laminin isoforms tested: Laminin-1 (alpha-1, beta-1, and gamma-1) and Laminin-2 (alpha-2, beta-1, and gamma-1). The antibody functionally inhibits Laminin in mouse and rat. It binds to Laminin and inhibits most, if not all, of its cell adhesion and growth promotive properties. Immunostaining is enhanced by antigen retrieval with pepsin, especially paraffin tissue. Suggested positive control: basement membranes (blood vessels of any tissue, tumors, nerve).

Laminin antibodies are widely used to label blood vessels and basement membranes.
Specifications

Specifications

Laminin
Polyclonal
DyLight® 488
LAMA1
Liquid
LAMA1, LAMA2, LAMB1, LAMC1
Laminin isolated from mouse EHS tumor.
IgG fraction
RUO
Antibody
Polyclonal
Human, Mouse, Rat
Immunohistochemistry (Frozen), Immunohistochemistry (Paraffin), Western Blot
0.6 mg/mL
50mM sodium borate with 0.05% sodium azide
P11047, P24043, P07942, P19137, P25391
LAMA, S-LAM-alpha, S-LAM alpha, S-laminin subunit alpha, laminin A chain, laminin subunit alpha-1, laminin-3 subunit alpha
Rabbit
IgG
100 μL
4° C, store in dark
Primary
16772, 3915, 3912, 284217, 3908, 316758
Documents
Provide Content Correction

We continue to work to improve your shopping experience and your feedback regarding this content is very important to us. Please use the form below to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Cancel Submit